Related Experiment Videos

Percutaneous transluminal coronary angioplasty: is what we see what we get?

N S Kleiman, A E Raizner, R Roberts

Journal of the American College of Cardiology

|September 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Surgical considerations on the use of the percutaneous ventricular assist device TandemHeart in critical aortic valve stenosis.

The Thoracic and cardiovascular surgeon·2009

Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.

Journal of thrombosis and haemostasis : JTH·2007

The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes.

Heart (British Cardiac Society)·2005

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.

Journal of thrombosis and haemostasis : JTH·2005

Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.

Journal of thrombosis and haemostasis : JTH·2004

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Heart (British Cardiac Society)·2003

See all related articles